SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-093268
Filing Date
2021-07-19
Accepted
2021-07-19 08:18:04
Documents
3
Period of Report
2021-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2122221d1_8k.htm 8-K 21867
2 EXHIBIT 99.1 tm2122221d1_ex99-1.htm EX-99.1 10759
3 GRAPHIC tm2122221d1_ex99-1img001.jpg GRAPHIC 2257
  Complete submission text file 0001104659-21-093268.txt   37140
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 211096913
SIC: 2834 Pharmaceutical Preparations